Pure Global AI
MFDS MFDS

MFDS Notice No. 2026-34 (28 April 2026)

Medical-device Approval, Notification and Review Regulations — Notice No. 2026-34 amendment
South KoreaMinistry of Food and Drug SafetyRegistrationCurrentness under review
Document status

Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.

What this code is

MFDS Notice No. 2026-34 (28 April 2026) is the official MFDS identifier for “Medical-device Approval, Notification and Review Regulations — Notice No. 2026-34 amendment”. MFDS Notice No. 2026-34 (28 April 2026) is the official identifier MFDS uses for this instrument.

Instrument
MFDS
Full name
MFDS Notice No. 2026-34 (28 April 2026)
Category
Registration
Source links
Source publication
Korean
Linked source text; confirm the publisher, publication details and any later amendment or consolidated version.
Readable HTML
1 language version
Direct citations can link to a specific article or section by appending its fragment identifier.
Dates
Published
—
Effective
—
Readable full text

Open a language version

Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.

About this regulation

Medical-device Approval, Notification and Review Regulations — Notice No. 2026-34 amendment

Complete nine-page formal amendment dated 28 April 2026 with operative changes, commencement/application clauses and prior-versus-amended comparisons. It amends the 2026-6 base, including the specified old-version manufacture/import branch and source-document translation provision. Prior and amended columns remain separate, and this source does not establish a general review-time promise. Source preservation does not certify blanket current legal effect or whole-country completeness.

MFDS Notice No. 2026-34 (28 April 2026) is the official identifier MFDS uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.